Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4.45 HKD | +1.37% | +3.25% | -35.41% |
Kurzporträt
Mitarbeiterzahl: 1 089
Umsatz nach Geschäftsbereich
HKD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development, Manufacturing, Commercialization and Services
100,0
%
| 727 | 100,0 % | 816 | 100,0 % | +12.21% |
Umsatz je Region
HKD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
China
91,1
%
| 661 | 90,8 % | 744 | 91,1 % | +12.60% |
Overseas
8,9
%
| 67 | 9,2 % | 72 | 8,9 % | +8.33% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jisong Cui
CEO | Chief Executive Officer | 62 | 03.11.15 |
Xin Fu
DFI | Director of Finance/CFO | 46 | 18.12. |
Kevin Gao
COO | Chief Operating Officer | - | - |
Xiang Yang Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.21 |
Chen Xiang Yang
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.10.15 |
Zhao Renbin
BRD | Director/Board Member | 55 | 03.11.15 |
Norman Kong
PRN | Corporate Officer/Principal | - | - |
Jessie Wang
LAW | General Counsel | - | - |
Xiaodong Jin
PRN | Corporate Officer/Principal | 52 | 28.06.20 |
Manish Tandon
PRN | Corporate Officer/Principal | - | 11.10.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Yigong Shi
FOU | Founder | 57 | 03.11.15 |
Kai Xian Chen
BRD | Director/Board Member | 79 | 01.03.20 |
Jisong Cui
CEO | Chief Executive Officer | 62 | 03.11.15 |
Lan Hu
BRD | Director/Board Member | 53 | 11.03.20 |
Zhao Renbin
BRD | Director/Board Member | 55 | 03.11.15 |
Dan Dan Dong
BRD | Director/Board Member | 40 | 11.10.23 |
Rong Gang Xie
BRD | Director/Board Member | 39 | 31.03.21 |
Ming Jin
BRD | Director/Board Member | 50 | 31.03.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 264 648 217 | 0 | 0 | 56,11 % |
Aktie B | 1 | 1 497 934 235 | 989 042 031 ( 66,03 %) | 0 |
Unternehmenskontakt
InnoCare Pharma Ltd.
Building 8, Changping District No. 8 Life Science Park Road
100084, Beijing
+86 10 6660 9999
http://www.innocarepharma.comSektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-35.41% | 1.14 Mrd. | |
-1.92% | 103 Mrd. | |
+0.84% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.03% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-15.03% | 15.52 Mrd. | |
+3.61% | 13.86 Mrd. | |
+34.81% | 12.04 Mrd. |
- Börse
- Aktien
- A2PVC2 Aktie
- Unternehmen InnoCare Pharma Limited